These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 30265552

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S, Laverman P, Joosten L, Eek A, Rutjes FP, van Delft FL, Boerman OC.
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
    Mohsin H, Fitzsimmons J, Shelton T, Hoffman TJ, Cutler CS, Lewis MR, Athey PS, Gulyas G, Kiefer GE, Frank RK, Simon J, Lever SZ, Jurisson SS.
    Nucl Med Biol; 2007 Jul; 34(5):493-502. PubMed ID: 17591549
    [Abstract] [Full Text] [Related]

  • 28. Design, Synthesis, and Biological Evaluation of 68Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging.
    Liu F, Liu T, Xu X, Guo X, Li N, Xiong C, Li C, Zhu H, Yang Z.
    Mol Pharm; 2018 Feb 05; 15(2):619-628. PubMed ID: 29278911
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
    Koumarianou E, Loktionova NS, Fellner M, Roesch F, Thews O, Pawlak D, Archimandritis SC, Mikolajczak R.
    Appl Radiat Isot; 2012 Dec 05; 70(12):2669-76. PubMed ID: 23037921
    [Abstract] [Full Text] [Related]

  • 31. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A, Schmitt S, Briat A, Ty N, Maigne L, Quintana M, Membreno R, Zeglis BM, Navarro-Teulon I, Pouget JP, Chezal JM, Miot-Noirault E, Moreau E, Degoul F.
    Theranostics; 2019 Dec 05; 9(22):6706-6718. PubMed ID: 31588245
    [Abstract] [Full Text] [Related]

  • 32. A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance.
    Roxin Á, Zhang C, Huh S, Lepage M, Zhang Z, Lin KS, Bénard F, Perrin DM.
    Bioconjug Chem; 2019 Apr 17; 30(4):1210-1219. PubMed ID: 30896929
    [Abstract] [Full Text] [Related]

  • 33. (44)Sc: an attractive isotope for peptide-based PET imaging.
    Hernandez R, Valdovinos HF, Yang Y, Chakravarty R, Hong H, Barnhart TE, Cai W.
    Mol Pharm; 2014 Aug 04; 11(8):2954-61. PubMed ID: 25054618
    [Abstract] [Full Text] [Related]

  • 34. [nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate.
    Li L, Jaraquemada-Peláez MG, Aluicio-Sarduy E, Wang X, Jiang D, Sakheie M, Kuo HT, Barnhart TE, Cai W, Radchenko V, Schaffer P, Lin KS, Engle JW, Bénard F, Orvig C.
    Inorg Chem; 2020 Feb 03; 59(3):1985-1995. PubMed ID: 31976659
    [Abstract] [Full Text] [Related]

  • 35. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
    Müller C, Domnanich KA, Umbricht CA, van der Meulen NP.
    Br J Radiol; 2018 Nov 03; 91(1091):20180074. PubMed ID: 29658792
    [Abstract] [Full Text] [Related]

  • 36. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
    Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C.
    Mol Pharm; 2016 Jun 06; 13(6):1979-87. PubMed ID: 27145400
    [Abstract] [Full Text] [Related]

  • 37. Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles.
    Stangl S, Nguyen NT, Brosch-Lenz J, Šimeček J, Weber WA, Kossatz S, Notni J.
    Eur J Nucl Med Mol Imaging; 2024 Sep 06; 51(11):3191-3201. PubMed ID: 38717591
    [Abstract] [Full Text] [Related]

  • 38. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC, Cho EH, Kim JJ, Choi SM, Lee SY, Nam SS, Park UJ, Park SH.
    Nucl Med Biol; 2015 Mar 06; 42(3):234-41. PubMed ID: 25498002
    [Abstract] [Full Text] [Related]

  • 39. Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
    Kumar N, Sharma AK, Guleria M, Shelar SB, Chakraborty A, Rakshit S, Kolay S, Satpati D, Das T.
    Mol Pharm; 2024 May 06; 21(5):2351-2364. PubMed ID: 38477252
    [Abstract] [Full Text] [Related]

  • 40. Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates.
    Müller C, Guzik P, Siwowska K, Cohrs S, Schmid RM, Schibli R.
    Molecules; 2018 Jun 16; 23(6):. PubMed ID: 29914162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.